Skip to main content
Clinical Trials/CTRI/2020/09/027867
CTRI/2020/09/027867Recruiting未知

Comparative efficacy of Diazepam, lorazepam and Oxazepam in the treatment of alcohol withdrawal syndrome

GMCH0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients with Alcohol Dependence Syndrome as per ICD-10
  • 2.Male patients in the age range of 18-60 years
  • 3.Willing to get admitted as independent patient

Exclusion Criteria

  • 1.Dependence on other substances except nicotine and caffeine
  • 2.Significant liver impairment ( liver enzymes increased more than 3 times) and unstable medical disorder
  • 3.History of complicated withdrawals in the past (DT, Withdrawal Seizures etc)
  • 4.History of hypersensitivity to diazepam, lorazepam and oxazepam
  • 5.Active psychotic patient
  • 6.Acutely suicidal patient
  • 7.Intoxicated patient

Investigators

Sponsor
GMCH

Similar Trials